Giant cell arteritis: controversial issues

Vnitrni Lekarstvi
|July 19, 2021
PubMed

Insights

Giant cell arteritis (GCA) diagnosis is evolving beyond temporal artery biopsy, with non-invasive methods gaining importance. Early treatment initiation is crucial, though relapses remain a challenge, prompting new therapeutic strategies.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Biology

Background:

  • Giant cell arteritis (GCA) is the most prevalent form of vasculitis affecting adults.
  • Diagnosis traditionally relies on temporal artery biopsy, but this is evolving.
  • Effective management requires early intervention to prevent complications.

Purpose of the Study:

  • To review the latest advancements in GCA diagnostics and treatment.
  • To highlight the increasing role of non-invasive diagnostic techniques.
  • To discuss current challenges and emerging therapies for GCA.

Main Methods:

  • Review of recent literature on GCA diagnostics and therapeutics.
  • Emphasis on non-invasive imaging modalities.
  • Discussion of novel pharmacological agents targeting inflammatory pathways.

Main Results:

  • Non-invasive methods are becoming increasingly vital for GCA diagnosis, complementing or potentially replacing biopsy.
  • Early diagnosis and prompt treatment initiation are critical for patient outcomes.
  • Modern treatments focus on specific inflammatory drivers, moving beyond standard glucocorticoids.
  • Frequent relapses continue to pose a significant challenge in GCA management.

Conclusions:

  • GCA diagnosis is shifting towards less invasive approaches.
  • Integrated diagnostic and therapeutic strategies are essential for managing GCA.
  • Ongoing research addresses controversial aspects from terminology to treatment efficacy.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
264
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
82
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
771